With the Revolutionary War at its end and the United States holding large parcels of land granted by the Treaty of Paris, the ...

RESTON, Va., May 05, 2026 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, today announced financial results for the first ...

InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program ...

Earnings Release Highlights First quarter GAAP Net Income of $63 million.First quarter Adjusted EBITDA of $473 million and Adjusted Free Cash ...

Revenue Less Ancillary Services increased 43.0% to $184.0 million in the First quarter of 2026, compared to $128.7 million in the First quarter of 2025. FX-Neutral Revenue Less Ancillary Services ...

SOUTH SAN FRANCISCO, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported a management ...

IMCIVREE® (setmelanotide) launched in the U.S. for acquired hypothalamic obesity; more than 150 patient start forms received in the first six weeks following FDA approval on March 19, 2026 -- -- First ...

The Xavantina Operations produced 5,495 ounces of gold at a C1 cash cost (1) of $2,120 per ounce and AISC (1) of $4,441 per ounce. Unit costs during the quarter reflected the lower production levels ...

LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic ...

Strong commercial execution across franchises with total revenues of $1.1 billion (+19% YoY) -- Zanidatamab HER2+ 1L GEA sBLA granted Priority Review; PDUFA date of August 25, 2026 -- Xywav ...

Solventum today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 HighlightsSales of ...

Alignment with the FDA on the Phase 3 trial design of VCN-01 (zabilugene almadenorepvec) for treatment of metastatic pancreatic ductal adenocarcinoma (PDAC) – – Additional data from VIRAGE Phase 2b ...